Nurmohamed M, Choy E, Charles-Schoeman C, et al. Impact of Tofacitinib Treatment Compared with Placebo or Methotrexate on Cardiovascular Risk Scores in Six Phase 3 Randomized Controlled Trials. ACR 2017, abstract 2966.
Cardiovasculaire risicofactoren bij primair syndroom van Sjögren
jan 2024 | Ritmestoornissen, Sjögren